3i Group report that they have established a single-use bioprocessing platform serving the biopharmaceutical sector with the acquisitions of Cellon, Silicone Altimex, and TBL Performance Plastics. Cellon, based in Luxembourg, and TBL, based in NJ, were acquired from their founder owners, who will continue to serve as leaders of the platform. Silicone Altimex had been a UK-based subsidiary of 3i-backed Q Holding that was acquired in 2015 from its owners, who remain advisors to the company. Source: Genetic Engineering News 21/1/2020